Testing tozorakimab for uncontrolled asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new drug called tozorakimab for adults whose asthma is not well controlled despite using medium-to-high dose inhaled steroids. The study aims to find the best dose and see if it reduces asthma attacks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had doctor-diagnosed asthma for at least 1 year.
- You use a medium or high dose inhaled steroid combined with a long-acting bronchodilator.
- Your asthma is not well controlled (score of 1.5 or higher on a standard asthma control questionnaire).
- You have had at least 1 severe asthma attack in the past year, and if only 1, your blood eosinophils or FeNO levels are elevated.
- You are not a current smoker and have not smoked more than 10 pack-years total.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This trial tests an investigational drug called TQC2731 for people with severe asthma that is not well controlled despite high-dose inhaled steroids. The study aims to see if this treatment can reduce asthma attacks.
This trial tests a drug called tezepelumab to see if it helps control severe asthma in adults. It may be an option if your asthma is hard to manage with current treatments and you have frequent symptoms or flare-ups.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.